Status:

NO_LONGER_AVAILABLE

Efficacy of Parecoxib on Patients With CRPS

Lead Sponsor:

Ruhr University of Bochum

Conditions:

Causalgia

Eligibility:

All Genders

18+ years

Brief Summary

The complex regional pain syndrom is a weighty disease that often results in a lifelong disability. Mostly this disease appears unilateral after comparatively mundane fractures or operations. In early...

Eligibility Criteria

Inclusion

  • Patients with saved diagnosis of CRPS of the upper extremity based on the current used criteria for diagnosis plus a positiv 3-phase-sceletal-scintilgraphy, if they show pathological PPT-values in QST on the ipsilateral site (Z-values \> 2 in age- and gender-based Z-transformation of the raw values)• age ≥ 18 years• Existence of an age-based normal creatinin-clearance (calculated with a defined formula)

Exclusion

  • Important cardiovascular illness for the purpose of heart failure (NYHA II - IV), coronary heart disease (CHD), peripheral artery occlusive disease (PAOD) or unstable hypertension (values constantly over 140/90 mm Hg)
  • Florid kidney disease
  • Cerebral disease
  • Neurological systemic disorder (exception: beginning polyneuropathy with normal values of the PPT on the opposite side)
  • Lesion of the median nerve (ipsi- oder contralateral)
  • Acute bleeding disease
  • Known ulcer of the stomach or duodenum
  • Inflammatory bowel disease
  • Positive anamnesis of a gastrointestinal bleeding in the last 5 years
  • Important hepatic dysfunction (Child- pugh \> 9)
  • Hypersensitivity to the agent or to sulfonamides
  • Known allergy to acetylsalicylic acid, nonsteroidal antiinflammatory drugs or other selectiv cyclooxygenase-inhibitors
  • Pregnancy and lactation period
  • Intake of one of the following drugs (current or in the last 3 days)
  • selective-serotonin-reuptake-inhibitor
  • cetoconazole
  • rifampicin
  • phenytoin
  • carbamazepine
  • dexamethasone or other systemic corticoids
  • traditional nonsteroidal antiphlogistics
  • cyclooxygenase-inhibitors
  • immunsupressives
  • TNF-α-inhibitors

Key Trial Info

Start Date :

Trial Type :

EXPANDED_ACCESS

End Date :

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01523379

Last Update

April 25 2012

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.